Ok, I KNOW this is a very standard thing, but well... I'm having trouble finding it in Google so I'm looking through a TSQL programming book.<BR><BR>Anyway, I figured I'd post it here and see who gets ...

The business of using artificial intelligence to find new drugs is starting to consolidate. The AI-powered drug discovery firm Recursion Pharmaceuticals will buy rival Exscientia in an all-stock deal ...

Q3 2025 Management View Christopher Gibson, Co-Founder and CEO, announced, "beginning January 1, the amazing Najat Khan is going to take over the role of CEO, President and Director of Recursion." ...

Recursion, a clinical-stage TechBio company, is set to present preliminary data from its Phase 1b/2 clinical trial, TUPELO, at the 2025 Digestive Disease Week (DDW) meeting on May 4, 2025, in San ...

Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.